Millions of people now reach for a gummy or a vape pen instead of a sleeping pill, convinced that cannabis for sleep is their ticket to a better night’s rest. Two fresh papers suggest the truth is far more complicated — and that “I sleep great on it” may not mean what you think. One is a new cannabis sleep study review from Cochrane, the group whose evidence summaries doctors treat as the closest thing medicine has to a final word. The other is an editorial written for the sleep doctors who field these questions every day.
The Cochrane review “Medical cannabis for the treatment of insomnia”, published in October 2026 in the Cochrane Database of Systematic Reviews, gathered every randomized trial its authors could find on medical cannabis for people with diagnosed insomnia — nine trials, 537 adults — and found no reliable sign that it improves sleep. Earlier in the year, an editorial in the Journal of Clinical Sleep Medicine, “What sleep physicians need to know about cannabis use for sleep” by researchers Rob Velzeboer and Wayne W. K. Lai, pulled together the wider evidence and landed on an equally uncomfortable conclusion: cannabis can make sleep feel better while doing little — or even something harmful — to sleep itself.
That gap between feeling and reality is the heart of the story. Cannabis has quietly become one of the most popular do-it-yourself sleep aids in the world, and doctors are increasingly fielding questions about it. Yet the science behind those questions is messy, contradictory, and frequently misunderstood by patients and clinicians alike.
Key Takeaways
People who use cannabis for sleep often report sleeping better, and that subjective experience appears to be genuine — but it does not reliably translate into objectively better sleep. The newest and most rigorous summary of the clinical trials, the October 2026 Cochrane review, found that medical cannabis may make little to no difference to sleep quality, total sleep time or daytime functioning in adults with insomnia, while causing slightly more side effects than a placebo; the authors stress that the trials are too small and too short to settle the question either way. Objective brain-activity measurements tell a similarly cautious story, including suppressed REM sleep and lighter, more fragmented sleep among long-term frequent users. The benefit also tends to fade over time as the body builds tolerance, which can push users toward higher doses. Perhaps most importantly, the feeling that you “can’t sleep without cannabis” may not be proof that it works — it can be a sign of withdrawal. None of this means cannabis is useless for sleep, but it does mean the popular narrative is oversimplified.
What the Latest Cannabis Sleep Study Found
The Cochrane review was led by Lucia B. Varela and senior author Luis I. Garegnani, with a team from the Cochrane Associate Centre at the Hospital Italiano de Buenos Aires and the University of Manitoba in Canada. Its method is the strictest one available for answering “does this treatment work?”: instead of running one new experiment, the authors collect every comparable randomized trial, check each for weaknesses, and pool the results. A randomized trial is the medical equivalent of a fair coin toss — people are assigned at random to get the real treatment or a dummy one, so any difference in outcome is more likely caused by the treatment rather than by who chose to take it.
The team found nine such trials, with 537 adults aged 18 to 76 who had been diagnosed with insomnia. Eight compared medical cannabis with a placebo; one compared it with amitriptyline, an older antidepressant often prescribed at low doses for sleep. The results were consistent across the outcomes that matter most to people who lie awake at night:
On sleep quality and satisfaction with sleep, seven studies covering 374 people found that cannabis may make little to no difference compared with placebo. On total sleep time, six studies with 194 people pointed the same way. On daytime functioning — the tiredness, poor focus and irritability that make insomnia a real problem — five studies with 144 people again found little to no meaningful effect. Quality of life was the one outcome that moved: three studies with 95 people suggested an improvement, but the review rated the certainty of that finding as very low, meaning the true effect could be quite different.
Side effects were more common on cannabis. Three crossover studies with 98 participants — designs in which the same person takes both the active product and the placebo at different times — reported that 37 people had unwanted effects only while on cannabis, none only while on placebo, 14 during both phases and 47 during neither. The effects were the familiar ones: dry mouth and dizziness above all. Cochrane’s background material notes that problems like these, along with memory lapses, increased appetite, tiredness and anxiety, can affect up to 80% of people who use medical cannabis.
Why “no reliable evidence” is not the same as “it doesn’t work”
The authors are careful about what their conclusion means. “This does not mean that medical cannabis is ineffective,” Varela said in the Cochrane press release. Their point is that the trials are too weak to answer the question. Most enrolled fewer than 50 people, most lasted only a few weeks, and the longest ran for 12. The products also varied widely — THC alone, CBD alone, or combinations of the two, given as oils, capsules or a gel — and the studies measured sleep in different ways, which makes their results hard to stack together. Many trials left out older adults and people with other health problems, even though insomnia is most common in exactly those groups. The literature search ran to 5 April 2025, and the review had no dedicated funding.
What matters for everyday readers is what the trials did not test. Nobody smoked or vaped flower, and nobody took a high-THC gummy from a shop. Every product was a regulated preparation given at a measured dose under supervision. So the review speaks to pharmaceutical-grade cannabis over a few weeks — not to the nightly, months-long, high-potency use that the Velzeboer and Lai editorial worries about most. The two papers fit together: one says the short-term trials show no clear benefit, the other explains why long-term habitual use may quietly make sleep worse. We have covered what the Cochrane review on cannabis and insomnia actually found in more depth, including how its certainty ratings work.
Why So Many People Are Desperate for Sleep
To understand why cannabis has become such a popular sleep aid, you first have to grasp the sheer scale of the problem it’s trying to solve. Poor sleep is not a niche complaint — it is a global health crisis hiding in plain sight.
A 2025 systematic analysis published in Sleep Medicine Reviews estimated that over 850 million adults worldwide have insomnia, a global prevalence of 16.2%, with almost 415 million of them experiencing severe insomnia. Broaden the definition slightly and the numbers climb dramatically: research suggests about one-third of adults worldwide experience insomnia symptoms, while 5–10% meet the criteria for a full insomnia disorder.
Sleep-disordered breathing adds another enormous layer. According to a landmark analysis in The Lancet Respiratory Medicine, an estimated 936 million adults aged 30–69 have mild to severe obstructive sleep apnoea, and 425 million have moderate to severe obstructive sleep apnoea, worldwide. Worse, the condition is wildly underdiagnosed — an estimated 80% of obstructive sleep apnea cases go undiagnosed, meaning huge numbers of people are tired without ever knowing why.
The economic toll is staggering. The widely cited RAND Europe study found that sleep deprivation costs the U.S. economy up to $411 billion a year, equal to 2.28% of its GDP, followed by Japan at up to $138 billion. In other words, lost sleep is not just a personal frustration — it’s a multibillion-dollar drag on entire nations. With stakes that high, it’s no surprise people are willing to try almost anything to sleep better, cannabis included.
Why the Research Is So Confusing
If you search online, you’ll find studies that seem to praise cannabis for sleep and others that warn against it. According to the editorial, this isn’t because scientists can’t agree — it’s because they’re often measuring completely different things.
“Better sleep” can mean a dozen things: falling asleep faster, waking up less, feeling more rested, or changes in the actual architecture of sleep stages. Studies routinely find that these measures disagree with one another, even within a single experiment. People frequently report sleeping better while objective recordings show their sleep got shorter or lighter. This is exactly the pattern seen in newer research, including a 2025 study on medical cannabis and sleep quality — patients consistently describe feeling more rested, but the objective picture is far more cautious. The Cochrane team ran into the same wall from the other side: because the nine trials used different questionnaires and measures, their results could not be cleanly combined.
Timing is another problem. Most rigorous trials test what happens shortly after a single dose or over a few weeks. But the real question patients have is about months or years of nightly use — whether the benefit lasts, whether the dose creeps up, and why it gets hard to sleep without it. Those long-term patterns are exactly what short trials fail to capture, and the 12-week ceiling in the Cochrane review shows how little long-term trial data exists.
Finally, “cannabis” isn’t one thing. Products vary wildly in their THC and CBD content, in how they’re taken, and in dose and timing (our science-based CBD guide breaks down how the two compounds differ). Lab trials tend to use low-dose, orally swallowed products that look nothing like the high-THC vapes and edibles people actually use at home.
What Happens to Your Brain When You Sleep on Cannabis
Here’s where the picture gets less reassuring. When researchers move past self-reports and actually record brain activity overnight, cannabis — and THC in particular — appears to delay and suppress REM sleep, the dream-rich stage tied to emotional processing and memory. The REM that does occur shows signs of being lower quality.
Other sleep stages don’t escape either. Deep sleep can become physiologically shallower, and the fine-grained electrical signatures of healthy sleep appear disrupted. Two recent observational studies of long-term frequent users found they spent more time awake during the night and slept more lightly than non-users. Observational studies like these follow people as they are rather than assigning a treatment, so they show a link rather than proof of cause — but they cover exactly the long-term use that the short clinical trials miss.
The relationship is especially nuanced for people with sleep apnea, a group where cannabis is increasingly being studied — including in research out of Minnesota on medical marijuana and sleep apnea. For these patients, the underlying breathing disorder, not the sleep aid, is usually the real driver of poor rest, which is why a proper diagnosis matters before any treatment.
There’s a more hopeful angle worth naming: cannabis may help some people indirectly, by easing the pain, anxiety, or nightmares that were keeping them awake in the first place. Conditions that cause physical discomfort — chronic pain, or the relentless itch of a skin disorder — can wreck sleep, and relieving them may improve rest as a side effect. Nightmare relief has also been reported, especially among people with PTSD. But even here, the measured sleep benefits tend to be small, and high-quality objective data is thin.
The Trap of “I Can’t Sleep Without It”
One of the editorial’s most practical insights concerns a phrase doctors hear constantly: I just can’t sleep without cannabis. It sounds like proof the drug is essential. The researchers argue it may be the opposite.
Cannabis withdrawal reliably causes trouble falling asleep, shorter total sleep, and a rebound surge of REM — effects that can linger for at least two weeks after stopping. So the sleepless night someone has when they skip a dose might not reveal a genuine ongoing need. It can simply be withdrawal. If nobody names that distinction, rebound insomnia gets mistaken for evidence that cannabis is irreplaceable, when the relationship may actually be a loop: poor sleep drives cannabis use, and cannabis use worsens sleep over time.
There’s also the bigger-picture cost. Frequent cannabis use — especially high-potency, near-daily use — is linked to psychiatric risks, most consistently psychosis. CBD appears to have a gentler safety profile than THC, though it isn’t risk-free. So the real question isn’t only whether cannabis helps you drift off, but whether nightly use is a trade worth making.
What to Do Instead
Neither paper issues a blanket verdict, and neither should anyone reading them. The editorial’s advice is pragmatic: figure out what’s really driving the sleeplessness — pain, anxiety, trauma — and treat that. Pay attention to whether the dose is escalating. And don’t overlook the genuine first-line treatment for chronic insomnia: cognitive behavioral therapy for insomnia, or CBT-I, a short course of talking therapy that retrains the habits and thoughts that keep people awake. It has strong evidence behind it, the Cochrane review names it as the main treatment for insomnia, and it may even help people reduce their reliance on cannabis for sleep.
For those weighing cannabis against conventional sleep medication, the comparison is worth taking seriously — a clinical trial comparing a Thai cannabis medicine with lorazepam for insomnia is one example of researchers trying to put these options head to head rather than relying on anecdote. The Cochrane authors are clear about what the field needs next: larger trials, longer follow-up, standardized products and outcomes, detailed reporting of harms, and participants who look like the real insomnia population, including older adults.
The bottom line is honest rather than tidy. If cannabis makes your sleep feel better, that experience is real and worth respecting. But feeling rested in the short term is not the same as sleeping well in the long term — and the best clinical evidence available today cannot yet show that cannabis closes that gap.
FAQ
Occasional use is different from nightly use. The research links frequent, high-THC use to escalating doses, withdrawal-related insomnia, and broader psychiatric risks, and no clinical trial has followed people taking cannabis for sleep for longer than 12 weeks. If you’re using it every night to sleep, that’s worth discussing with a doctor rather than treating as a settled solution.
Not necessarily. Studies repeatedly show that people can feel they slept better while objective measurements show shorter, lighter, or more disrupted sleep. When the new Cochrane review compared cannabis with placebo in controlled trials, it found little to no difference in sleep quality or sleep time. The subjective improvement is real, but it doesn’t reliably predict genuine, lasting sleep quality.
CBD appears to have a better safety profile than THC, particularly regarding intoxication and psychosis risk. However, current evidence does not allow reliable predictions of sleep benefit based on cannabinoid type, dose, or route — the Cochrane trials tested THC, CBD and combinations and could not pool them into a clear signal — and CBD is not entirely risk-free.
It depends on the product and the state. No cannabis product is approved by the Food and Drug Administration to treat insomnia. Since an April 2026 federal order, FDA-approved cannabis medicines and marijuana covered by a qualifying state medical license sit in Schedule III, while other marijuana, including adult-use products, remains in Schedule I pending a broader rescheduling decision. Whether insomnia qualifies for a medical card is set by each state. Separately, a federal law passed in November 2025 redefines hemp and will make most intoxicating hemp-derived THC products, including many “sleep gummies,” federally illegal; its start date is currently scheduled for December 11, 2026. Rules change frequently, so check current state and federal law.
Disclaimer
This article is for general informational and educational purposes only and does not constitute medical or legal advice, nor a recommendation to use or avoid any substance. Cannabis laws and regulations vary by location, and in many places possession or use remains a criminal offence. Insomnia can be a symptom of an underlying medical or psychiatric condition that needs proper assessment. Always consult a qualified healthcare professional before starting, changing, or stopping any sleep aid or treatment, including cannabis.
